# Carnosine Supplementation on Quantity/Quality of Oral Salivae.

> **NCT04295525** · NA · UNKNOWN · sponsor: **University of Milan** · enrollment: 60 (estimated)

## Conditions studied

- Oral Diseases

## Interventions

- **DIETARY_SUPPLEMENT:** 400 mg mucoadhesive oral tablet
- **DIETARY_SUPPLEMENT:** placebo mucoadhesive oral tablet

## Key facts

- **NCT ID:** NCT04295525
- **Lead sponsor:** University of Milan
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-01
- **Primary completion:** 2022-12-01
- **Final completion:** 2022-12-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04295525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04295525, "Carnosine Supplementation on Quantity/Quality of Oral Salivae.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04295525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*